Table of Contents
Chemotherapy Research and Practice
Volume 2014 (2014), Article ID 520701, 8 pages
http://dx.doi.org/10.1155/2014/520701
Clinical Study

A Postauthorization Survey to Document the Therapeutic Management of Oxaliplatin as a First-Line Chemotherapy Regimen in South Africa in Patients with Metastatic Colorectal Cancer

1Department of Medical Oncology, Faculty of Medical Sciences, University of Pretoria, Prinshof Campus, Steve Biko Academic Hospital, Dr. Savage Road, Pretoria 0001, South Africa
2Medical Department, Sanofi South Africa, Midrand 1682, South Africa

Received 13 January 2014; Revised 19 March 2014; Accepted 19 March 2014; Published 10 April 2014

Academic Editor: Vassilis Georgoulias

Copyright © 2014 Lydia M. Dreosti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Lydia M. Dreosti, Alicia McMaster, and Rashem Mothilal, “A Postauthorization Survey to Document the Therapeutic Management of Oxaliplatin as a First-Line Chemotherapy Regimen in South Africa in Patients with Metastatic Colorectal Cancer,” Chemotherapy Research and Practice, vol. 2014, Article ID 520701, 8 pages, 2014. doi:10.1155/2014/520701